Corrigendum to “Sodium selenite attenuates hyperglycemia-exacerbated cerebral ischemia/reperfusion injury by inhibiting the Fas/FasL/PUMA apoptotic pathway” [Pathol. - Res. Pract. 283 (2026) 156494]
Pathology - Research and Practice · 2026-09 · 285 · 156541
DOI: 10.1016/j.prp.2026.156541 ↗Kurz gefasst
Korrektur in der Zeitschrift Pathology - Research and Practice, 2026-09. Verfasst von Lan Yang und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medicine, Ningxia Medical University, Yinchuan 750004, China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- School of Basic Medicine, Ningxia Medical University, Yinchuan 750004, China.
- Department of Gastroenterology, Ningxia Hui Autonomous Region People's Hospital, Yinchuan 750004, China.
- Department of Pathology, The First Affiliated Hospital of Henan University of Chinese Medicine, Zhengzhou 450000, China.
- School of Basic Medicine, Ningxia Medical University, Yinchuan 750004, China. Electronic address: 1203220205@qq.com.
Zitieren
APA
Yang, L., Ding, F., Yin, X., Zhao, S., Chang, Y., Zhang, J., Huang, N., Wang, W., & Jing, L. (2026). Corrigendum to “Sodium selenite attenuates hyperglycemia-exacerbated cerebral ischemia/reperfusion injury by inhibiting the Fas/FasL/PUMA apoptotic pathway” [Pathol. - Res. Pract. 283 (2026) 156494]. Pathology - Research and Practice, 285, 156541. https://doi.org/10.1016/j.prp.2026.156541
Vancouver
Yang L, Ding F, Yin X, Zhao S, Chang Y, Zhang J, et al. Corrigendum to “Sodium selenite attenuates hyperglycemia-exacerbated cerebral ischemia/reperfusion injury by inhibiting the Fas/FasL/PUMA apoptotic pathway” [Pathol. - Res. Pract. 283 (2026) 156494]. Pathology - Research and Practice. 2026;285:156541. doi:10.1016/j.prp.2026.156541
BibTeX
@article{Yang2026,
author = {Yang, Lan and Ding, Feng and Yin, Xida and Zhao, Shuai and Chang, Yue and Zhang, Jingwen and Huang, Ningbo and Wang, Wenjun and Jing, Li},
title = {Corrigendum to “Sodium selenite attenuates hyperglycemia-exacerbated cerebral ischemia/reperfusion injury by inhibiting the Fas/FasL/PUMA apoptotic pathway” [Pathol. - Res. Pract. 283 (2026) 156494]},
journal = {Pathology - Research and Practice},
year = {2026},
volume = {285},
pages = {156541},
doi = {10.1016/j.prp.2026.156541}
}
EUVIMED